Bio-Rad Laboratories, Inc.Class A vs. Revvity, Inc.
Bio-Rad Laboratories, Inc.Class A and Revvity, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BIO | RVTY | |
|---|---|---|
| Market Cap | $9.92 billion | $17.31 billion |
RVTY leads on 1 of 1 size & scale factors.
Dividend
| BIO | RVTY | |
|---|---|---|
| Dividend Yield | — | 0.18% |
BIO and RVTY split the dividend factors evenly.
Risk & Sentiment
| BIO | RVTY | |
|---|---|---|
| Short Interest | 2.44% | 2.98% |
BIO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, RVTY overview, RVTY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.